Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis

Angie C. Jelin, Rita Sharshiner, Aaron Caughey

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To evaluate maternal co-morbidities and adverse perinatal outcomes associated with cystic fibrosis (CF). Methods: This is a retrospective cohort study of 2 178 954 singleton pregnancies at ≥20 weeks’ gestation with and without CF in the state of California during the years 2005–2008. ICD-9 codes and linked hospital discharge and vital statistics data were utilized. Rates of maternal co-morbidities, fetal congenital anomalies and adverse perinatal outcomes were compared in those with CF and those without. Maternal co-morbidities included gestational hypertension, preeclampsia, gestational diabetes and primary cesarean delivery. Perinatal outcomes included neonatal demise, preterm birth, intrauterine growth restriction, macrosomia, anomaly, fetal demise, asphyxia, respiratory distress syndrome, jaundice, intraventricular hemorrhage, hypoglycemia and necrotizing enterocolitis. Results: The cohort included 2 178 954 pregnancies of which 77 mothers had CF. Mothers with CF were more likely to have pre-gestational diabetes and had higher rates of primary cesarean delivery. Neonates delivered to mothers with CF were more likely to be born preterm and have congenital anomalies but otherwise were not at increased risk for significant neonatal morbidity or mortality when adjusted for gestational age. Conclusion: Mothers with CF are more likely to have pre-gestational diabetes, deliver preterm (

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalJournal of Maternal-Fetal and Neonatal Medicine
DOIs
StateAccepted/In press - Apr 4 2016

Fingerprint

Cystic Fibrosis
Mothers
Morbidity
Gestational Diabetes
International Classification of Diseases
Pregnancy
Pregnancy Induced Hypertension
Vital Statistics
Necrotizing Enterocolitis
Fetal Death
Asphyxia
Premature Birth
Pre-Eclampsia
Jaundice
Hypoglycemia
Gestational Age
Cohort Studies
Retrospective Studies
Hemorrhage
Mortality

Keywords

  • Congenital anomalies
  • cystic fibrosis
  • preterm delivery

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis. / Jelin, Angie C.; Sharshiner, Rita; Caughey, Aaron.

In: Journal of Maternal-Fetal and Neonatal Medicine, 04.04.2016, p. 1-4.

Research output: Contribution to journalArticle

@article{6331332910d04e1a9cd2631b9293f9ae,
title = "Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis",
abstract = "Objective: To evaluate maternal co-morbidities and adverse perinatal outcomes associated with cystic fibrosis (CF). Methods: This is a retrospective cohort study of 2 178 954 singleton pregnancies at ≥20 weeks’ gestation with and without CF in the state of California during the years 2005–2008. ICD-9 codes and linked hospital discharge and vital statistics data were utilized. Rates of maternal co-morbidities, fetal congenital anomalies and adverse perinatal outcomes were compared in those with CF and those without. Maternal co-morbidities included gestational hypertension, preeclampsia, gestational diabetes and primary cesarean delivery. Perinatal outcomes included neonatal demise, preterm birth, intrauterine growth restriction, macrosomia, anomaly, fetal demise, asphyxia, respiratory distress syndrome, jaundice, intraventricular hemorrhage, hypoglycemia and necrotizing enterocolitis. Results: The cohort included 2 178 954 pregnancies of which 77 mothers had CF. Mothers with CF were more likely to have pre-gestational diabetes and had higher rates of primary cesarean delivery. Neonates delivered to mothers with CF were more likely to be born preterm and have congenital anomalies but otherwise were not at increased risk for significant neonatal morbidity or mortality when adjusted for gestational age. Conclusion: Mothers with CF are more likely to have pre-gestational diabetes, deliver preterm (",
keywords = "Congenital anomalies, cystic fibrosis, preterm delivery",
author = "Jelin, {Angie C.} and Rita Sharshiner and Aaron Caughey",
year = "2016",
month = "4",
day = "4",
doi = "10.3109/14767058.2016.1161747",
language = "English (US)",
pages = "1--4",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis

AU - Jelin, Angie C.

AU - Sharshiner, Rita

AU - Caughey, Aaron

PY - 2016/4/4

Y1 - 2016/4/4

N2 - Objective: To evaluate maternal co-morbidities and adverse perinatal outcomes associated with cystic fibrosis (CF). Methods: This is a retrospective cohort study of 2 178 954 singleton pregnancies at ≥20 weeks’ gestation with and without CF in the state of California during the years 2005–2008. ICD-9 codes and linked hospital discharge and vital statistics data were utilized. Rates of maternal co-morbidities, fetal congenital anomalies and adverse perinatal outcomes were compared in those with CF and those without. Maternal co-morbidities included gestational hypertension, preeclampsia, gestational diabetes and primary cesarean delivery. Perinatal outcomes included neonatal demise, preterm birth, intrauterine growth restriction, macrosomia, anomaly, fetal demise, asphyxia, respiratory distress syndrome, jaundice, intraventricular hemorrhage, hypoglycemia and necrotizing enterocolitis. Results: The cohort included 2 178 954 pregnancies of which 77 mothers had CF. Mothers with CF were more likely to have pre-gestational diabetes and had higher rates of primary cesarean delivery. Neonates delivered to mothers with CF were more likely to be born preterm and have congenital anomalies but otherwise were not at increased risk for significant neonatal morbidity or mortality when adjusted for gestational age. Conclusion: Mothers with CF are more likely to have pre-gestational diabetes, deliver preterm (

AB - Objective: To evaluate maternal co-morbidities and adverse perinatal outcomes associated with cystic fibrosis (CF). Methods: This is a retrospective cohort study of 2 178 954 singleton pregnancies at ≥20 weeks’ gestation with and without CF in the state of California during the years 2005–2008. ICD-9 codes and linked hospital discharge and vital statistics data were utilized. Rates of maternal co-morbidities, fetal congenital anomalies and adverse perinatal outcomes were compared in those with CF and those without. Maternal co-morbidities included gestational hypertension, preeclampsia, gestational diabetes and primary cesarean delivery. Perinatal outcomes included neonatal demise, preterm birth, intrauterine growth restriction, macrosomia, anomaly, fetal demise, asphyxia, respiratory distress syndrome, jaundice, intraventricular hemorrhage, hypoglycemia and necrotizing enterocolitis. Results: The cohort included 2 178 954 pregnancies of which 77 mothers had CF. Mothers with CF were more likely to have pre-gestational diabetes and had higher rates of primary cesarean delivery. Neonates delivered to mothers with CF were more likely to be born preterm and have congenital anomalies but otherwise were not at increased risk for significant neonatal morbidity or mortality when adjusted for gestational age. Conclusion: Mothers with CF are more likely to have pre-gestational diabetes, deliver preterm (

KW - Congenital anomalies

KW - cystic fibrosis

KW - preterm delivery

UR - http://www.scopus.com/inward/record.url?scp=84962439629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962439629&partnerID=8YFLogxK

U2 - 10.3109/14767058.2016.1161747

DO - 10.3109/14767058.2016.1161747

M3 - Article

C2 - 26940249

AN - SCOPUS:84962439629

SP - 1

EP - 4

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

ER -